Bouchey Financial Group LTD Pacira Bio Sciences, Inc. Transaction History

Bouchey Financial Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$51.49 - $81.64 $283,195 - $449,020	5,500 New	5,500 $321,000
Q2 2022 Jul 26, 2022	SELL	$51.49 - $81.64 $283,195 - $449,020	-5,500 Closed	0 $0
Q2 2021 Aug 24, 2021	BUY	$59.18 - $69.99 $325,490 - $384,945	5,500 New	5,500 $334,000
Q2 2021 Aug 12, 2021	SELL	$59.18 - $69.99 $325,490 - $384,945	-5,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$59.31 - $78.82 $59,310 - $78,820	1,000 Added 22.22%	5,500 $385,000
Q2 2020 Jul 28, 2020	BUY	$30.8 - $52.47 $138,600 - $236,115	4,500 New	4,500 $236,000
Q1 2020 Apr 09, 2020	SELL	$28.4 - $50.7 $127,800 - $228,150	-4,500 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$36.31 - $46.83 $163,395 - $210,735	4,500 New	4,500 $204,000
Q4 2018 Jan 14, 2019	SELL	$41.31 - $52.16 $185,895 - $234,719	-4,500 Closed	0 $0
Q3 2018 Oct 09, 2018	BUY	$32.85 - $52.0 $147,825 - $234,000	4,500 New	4,500 $221,000
Q1 2018 Apr 09, 2018	SELL	$29.98 - $46.35 $134,910 - $208,575	-4,500 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$31.85 - $46.95 $143,325 - $211,275	4,500	4,500 $205,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Bouchey Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Bouchey Financial Group LTD with notifications on news.